Month: April 2019

Neutrophils escort circulating tumour cells to enable cell cycle progression A better understanding of the options that outline the interaction between cancer cells and immune […]

The projected timeframe until cervical cancer elimination in Australia: a modelling study Background In 2007, Australia was one in all the primary countries to introduce […]

Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns Sickle cell disease (SCD) may be a severe […]

LncRNA PVT1 regulates VEGFC through inhibiting miR‐128 in bladder cancer cells Long noncoding ribonucleic acid PVT1 is taken into account to be Associate in Nursing […]

Cholesterol derived carbon quantum dots as fluorescence probe for the specific detection of hemoglobin in diluted human blood samples In the current decade, carbon quantum […]

Nivolumab-induced aplastic anemia: A case report and literature review Directed therapy at the programmed cell death-1 receptor has incontestible effectiveness in non-small-cell carcinoma, pathologic process […]

Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia β-thalassemia could be a hereditary disorder with restricted approved treatment […]

The relation between ABO blood types and clinical and platelet function parameters in patients who underwent percutaneous coronary intervention Background ABO blood teams are related […]

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma BACKGROUND Patients with diffuse giant B-cell malignant neoplastic disease that’s refractory to primary and second-line […]

Lack of association between obesity and aggressiveness of differentiated thyroid cancer Purpose  Aim of this study was to guage the association between body mass index […]